8-K: Cingulate Inc. Granted Nasdaq Extension, Implements 1-for-12 Reverse Stock Split to Regain Compliance

Cingulate Inc. received an extension from Nasdaq to meet minimum bid price requirements and will implement a 1-for-12 reverse stock split on August 9, 2024.

Summary

• Cingulate Inc. was granted an exception by the Nasdaq Hearings Panel to demonstrate compliance with the $1.00 minimum bid price requirement.
• The company must achieve a closing bid price of $1.00 or more per share for at least ten consecutive trading sessions by August 23, 2024.
• To meet this requirement, Cingulate will implement a 1-for-12 reverse stock split effective August 9, 2024, at 12:01 a.m. Eastern Time.
• The reverse stock split will consolidate every twelve existing shares of common stock into one new share.
• The reverse stock split will not change the par value of the common stock or the authorized number of shares.
• Fractional shares resulting from the split will be rounded up to the nearest whole share.
• All outstanding securities, such as stock options and warrants, will be adjusted accordingly.

Sentiment

Score: 5

Explanation: The document indicates a necessary but potentially risky action to maintain listing. The reverse stock split is a common but not always successful strategy. The sentiment is neutral to slightly negative due to the underlying issues.

Positives

• The Nasdaq Hearings Panel granted Cingulate an exception, providing additional time to regain compliance.
• The reverse stock split is a proactive measure to meet the minimum bid price requirement.
• The company has a clear path to potentially maintain its Nasdaq listing.

Negatives

• The company was previously notified of non-compliance with the minimum bid price requirement.
• The reverse stock split reduces the number of outstanding shares, which can be perceived negatively by some investors.
• The company is subject to a discretionary panel monitor through May 21, 2025.

Risks

• The Nasdaq Panel reserves the right to reconsider the exception if any events occur that make continued listing inadvisable.
• The company must achieve and maintain a $1.00 minimum bid price for ten consecutive trading sessions by August 23, 2024, or face delisting.
• There is no guarantee that the reverse stock split will result in a sustained increase in the stock price.

Future Outlook

Cingulate must demonstrate compliance with the $1.00 minimum bid price requirement by August 23, 2024, to maintain its Nasdaq listing. The company will be monitored by the Nasdaq panel until May 21, 2025.

Management Comments

• The Board of Directors approved a 1-for-12 reverse stock split ratio.
• The company is working to regain compliance with Nasdaq listing requirements.

Industry Context

Reverse stock splits are a common strategy for companies facing delisting due to low share prices. This action is often seen in the biotechnology and pharmaceutical sectors where companies may experience volatility in their stock price.

Comparison to Industry Standards

• Many companies facing similar delisting notices from Nasdaq have implemented reverse stock splits to regain compliance, including companies like Cassava Sciences (SAVA) and Ocugen (OCGN).
• The 1-for-12 ratio is within the typical range for reverse stock splits, which can vary from 1-for-2 to 1-for-20 or more.
• The success of a reverse stock split in maintaining listing depends on the company's ability to improve its financial performance and investor confidence.

Stakeholder Impact

• Shareholders will see a reduction in the number of shares they own, but their percentage ownership will remain the same.
• The reverse stock split may impact the stock price, potentially affecting investor confidence.
• The company's ability to maintain its Nasdaq listing is crucial for its long-term viability.

Next Steps

• Cingulate must achieve a closing bid price of $1.00 or more per share for ten consecutive trading sessions by August 23, 2024.
• The company will continue to be monitored by the Nasdaq panel through May 21, 2025.

Key Dates

Keywords

reverse stock split, Nasdaq, minimum bid price, delisting, compliance, Cingulate Inc., stock split, listing rule